Detalhe da pesquisa
1.
Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection.
Nat Immunol
; 23(1): 40-49, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34937928
2.
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.
Nat Immunol
; 22(5): 620-626, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33674800
3.
Author Correction: Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.
Nat Immunol
; 22(7): 928, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34017126
4.
Perceptions of adolescents on the COVID-19 pandemic and returning to school: qualitative questionnaire survey, September 2020, England.
BMC Pediatr
; 22(1): 456, 2022 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35906588
5.
Hospital length of stay for COVID-19 patients: Data-driven methods for forward planning.
BMC Infect Dis
; 21(1): 700, 2021 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34294037
6.
Implementation of preventive measures to prevent COVID-19: a national study of English primary schools in summer 2020.
Health Educ Res
; 36(3): 272-285, 2021 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33860299
7.
Screening for asymptomatic neurosyphilis in HIV patients after treatment of early syphilis: an observational study.
Sex Transm Infect
; 94(5): 337-339, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28196838
8.
Antibody Persistence After Primary SARS-CoV-2 Infection and Protection Against Future Variants Including Omicron in Adolescents: National, Prospective Cohort Study.
Pediatr Infect Dis J
; 42(6): 496-502, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36916856
9.
Nasal mucosal IgA levels against SARS-CoV-2 and seasonal coronaviruses are low in children but boosted by reinfection.
J Infect
; 87(5): 403-412, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37660754
10.
Immunological imprinting of humoral immunity to SARS-CoV-2 in children.
Nat Commun
; 14(1): 3845, 2023 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37386081
11.
Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial.
Lancet Infect Dis
; 23(2): 183-195, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36272432
12.
Paediatric acute hepatitis of unknown aetiology: a national investigation and adenoviraemia case-control study in the UK.
Lancet Child Adolesc Health
; 7(11): 786-796, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37774733
13.
An Overview of SARS-CoV-2 Molecular Diagnostics in Europe.
Clin Lab Med
; 42(2): 161-191, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35636820
14.
Parents' and teachers' attitudes to and experiences of the implementation of COVID-19 preventive measures in primary and secondary schools following reopening of schools in autumn 2020: a descriptive cross-sectional survey.
BMJ Open
; 12(9): e052171, 2022 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36171032
15.
Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study.
Lancet Respir Med
; 10(11): 1061-1073, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35988572
16.
Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study.
Lancet Infect Dis
; 22(2): 183-195, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34756186
17.
SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurements.
Microbiol Spectr
; 10(1): e0078621, 2022 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34985331
18.
Emergence of the delta variant and risk of SARS-CoV-2 infection in secondary school students and staff: Prospective surveillance in 18 schools, England.
EClinicalMedicine
; 45: 101319, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35233517
19.
mRNA or ChAd0x1 COVID-19 Vaccination of Adolescents Induces Robust Antibody and Cellular Responses With Continued Recognition of Omicron Following mRNA-1273.
Front Immunol
; 13: 882515, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35720281
20.
Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial.
Nat Commun
; 13(1): 7284, 2022 11 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36435798